Correlation Between Edesa Biotech and Tectonic Therapeutic,

Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and Tectonic Therapeutic, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and Tectonic Therapeutic, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Edesa Biotech and Tectonic Therapeutic,, you can compare the effects of market volatilities on Edesa Biotech and Tectonic Therapeutic, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of Tectonic Therapeutic,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and Tectonic Therapeutic,.

Diversification Opportunities for Edesa Biotech and Tectonic Therapeutic,

-0.89

Correlation Coefficient

Edesa Biotech  Tectonic Therapeutic,

Pay attention - limited upside

The 3 months correlation between Edesa and Tectonic is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and Tectonic Therapeutic, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tectonic Therapeutic, and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with Tectonic Therapeutic,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tectonic Therapeutic, has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and Tectonic Therapeutic, go up and down completely randomly.

Pair Corralation between Edesa Biotech and Tectonic Therapeutic,

Given the investment horizon of 90 days Edesa Biotech is expected to under-perform the Tectonic Therapeutic,. In addition to that, Edesa Biotech is 1.6 times more volatile than Tectonic Therapeutic,. It trades about -0.15 of its total potential returns per unit of risk. Tectonic Therapeutic, is currently generating about -0.01 per unit of volatility. If you would invest  4,804  in Tectonic Therapeutic, on September 24, 2024 and sell it today you would lose (113.00) from holding Tectonic Therapeutic, or give up 2.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Edesa Biotech  vs.  Tectonic Therapeutic,

Edesa Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Tectonic Therapeutic,

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tectonic Therapeutic, are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Tectonic Therapeutic, showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Edesa Biotech and Tectonic Therapeutic,

The main advantage of trading using opposite Edesa Biotech and Tectonic Therapeutic, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, Tectonic Therapeutic, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tectonic Therapeutic, will offset losses from the drop in Tectonic Therapeutic,'s long position.

The idea behind Edesa Biotech and Tectonic Therapeutic, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.